% 112.68 99.26 14% Earnings before interest tax and deprecation 114.01 80.11 42% 270.02 218.00 24% % Earnings before interest tax and deprecation 29% 25% 4% 26% 24% 2% Other income /(expenses) 5.00 2.84 76
% 986.58 876.62 13% Gross margin 108.76 79.99 36% 417.39 332.84 25% % Gross margin 30% 25% 4% 30% 28% 2% Administrative expenses 40.51 38.10 6% 153.19 137.37 12% Earnings before interest, taxes and
changed from December 31, 2018 as follows; The Statements of Financial Position (Unit: Million Baht) Consolidated Financial Statement Dec 31, 2019 Dec 31, 2018 YoY Current Assets 1,625.47 700.84 869.01
of hospital operations 257.36 226.88 13% Gross margin 125.57 86.97 44% % Gross margin 33% 28% 5% Administrative expenses 47.84 35.48 35% Earnings before interest, taxes and depreciation 105.66 75.92 39
. Administrative Expenses Administrative expenses decreased by 5% comparing to 2Q19 (not included non-recurring expenses of THB. 22.5 million). This was attributable to staff expenses. Earnings before interest
incomes and consumption since quarter 1/2020, the situation was moving without ending limited, consequence, consumers had changed behavior to spend more carefully and on necessary consumption, moreover they
integration of acquired businesses, the start of earning recovery in our high-volume Necessities business and our stable but higher-margin HVA business. We delivered record earnings and cash flows and expect
achieved strong earnings, a growth of 49% in core EBIDTA or $749 mil- lion which is on track to deliver over $1 Billion in annual EBITDA in 2017, the first time in the history of the Company. The strong
million (THB 8.4 billion), -7% YoY, Core EBITDA margin 10% Core Net profit after tax of $128 million (THB 4.0 billion), -27% YoY Core Earnings Per Share of THB 0.67, -32% YoY Operating Cash Flow of
the rest of 2019. Earnings from the Olefins and Specialty Chemicals businesses are expected to remain weak for the rest of 2019. This changed ecosystem necessitated a comprehensive review of our 2019